Eiko Lifesciences Ltd — Quarterly Results & Earnings

₹49.74

-3.48%

Profit Growth YoY285.71%Latest quarter

Sales Growth YoY43.01%Latest quarter

Sales CAGR 5Y29.35%5 year compound

Profit CAGR 5Y25.18%5 year compound

📋

Quarterly Performance

YoY Profit Growth+285.71%

🔥 Exceptional growth

YoY Sales Growth+43.01%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

N/A

EPS Growth 5Y

20.61%

Interest Coverage

Higher = safer debt servicing

20.84

ROE

N/A

ROCE

N/A

💡

Growth Analysis

Eiko Lifesciences Ltd reported YoY profit growth of 285.71% and revenue growth of 43.01% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 29.35% and profits at 25.18% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Eiko Lifesciences Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Specialty Chemicals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.